Page 30 - bon-dia-aruba-20201203
P. 30

A30     world news
                 Diahuebs 3 December 2020

                            Britain approves vaccine and will begin shots within days



                                                                                                                        dation  has  only  been  given  by  the
                                                                                                                        MHRA following the most rigorous
                                                                                                                        scientific assessment of every piece of
                                                                                                                        data.”

                                                                                                                        Getting  that  message  to  the  public
                                                                                                                        will be critical if any vaccination pro-
                                                                                                                        gram is to be successful. Some people
                                                                                                                        are worried about getting any vaccine,
                                                                                                                        never mind a new one.

                                                                                                                        “But  I  think  once  they  understand
                                                                                                                        and see everyone else having it with-
                                                                                                                        out hesitation, I think you’ll find that
                                                                                                                        people will go and have it,” Jacque-
                                                                                                                        line  Roubians,  a  76-year-old  retired
                                                                                                                        nurse, said at Brixton Market in Lon-
                                                                                                                        don. “People are dying of COVID, so
                                                                                                                        you make that decision: Do you want
                                                                                                                        to die or do you want the vaccine?”

                                                                                                                        In addition to the huge logistical chal-
                                                                                                                        lenges  of  distributing  the  vaccines,
                                                                                                                        the  Pfizer-BioNTech  one  must  be
                                                                                                                        stored and shipped at ultra-cold tem-
                                                                                                                        peratures of around minus 70 degrees
                                                                                                                        Celsius  (minus  94  degrees  Fahren-
                                                                                                                        heit).

                                                                                                                        Pfizer said that it has developed ship-
                                                                                                                        ping containers that use dry ice and
                                                                                                                        that GPS-enabled sensors will allow
            (AP) — Britain became the first  als showed it was 95% effective and  said,  though  the  exact  number  will  the company to track each shipment
            country in the world to authorize  offered significant protection for old-  depend on how fast it can be manu-  and ensure it stays cold.
            a  rigorously  tested  COVID-19  er  people.  The  vaccine  remains  ex-  factured and checked for quality.
            vaccine Wednesday and could be  perimental while final testing is done.                                     Every country has different rules for
            dispensing shots within days — a                                        BioNTech, which owns the vaccine,  determining  when  an  experimental
            historic  step  toward  eventually  “This  is  an  unprecedented  piece  of  said it has so far signed deals to supply  vaccine  is  safe  and  effective  enough
            ending the scourge that has killed  science,”  given  that  the  vaccine  was  570 million doses worldwide in 2021,  to use. China and Russia have offered
            more  than  1.4  million  people  authorized less than a year after the  with  options  to  deliver  600  million  different  vaccines  to  their  citizens
            around the globe.                   virus  was  discovered,  said  David  more. It hopes to supply at least 1.3  before they had gone through large-
                                                Harper,  senior  consulting  fellow  in  billion in 2021.               scale, late-stage testing.
            In  giving  the  go-ahead  for  emer-  global health at the Chatham House
            gency  use  of  the  vaccine  developed  think tank.                    That is only a fraction of what will be  Hours after Britain's announcement,
            by  American  drugmaker  Pfizer  and                                    needed as public health officials try to  Russian  President  Vladimir  Putin,
            Germany’s BioNTech, Britain vault-  Prime  Minister  Boris  Johnson  de-  vaccinate much of the world’s popu-  not to be outdone, ordered the start
            ed past the United States by at least a  clared  that  the  “searchlights  of  sci-  lation. Experts have said several vac-  of  a  large-scale  COVID-19  vaccina-
            week. The U.S. Food and Drug Ad-    ence”  had  picked  out  the  “invisible  cines will be required to quickly end  tion campaign by late next week, with
            ministration is not scheduled to con-  enemy.”  He  said  that  in  developing  the pandemic.               doctors and teachers to be first in line
            sider the vaccine until Dec. 10.    the vaccine, scientists had performed                                   to receive the Sputnik V shot, whose
                                                “biological ju jitsu” by turning the vi-  In  Britain,  the  first  shots  will  go  to  name was inspired by the 1957 satel-
            “This is a day to remember, frankly,  rus on itself.                    nursing home patients and those who  lite that was one of Moscow's proud-
            in  a  year  to  forget,"  British  Health                              care  for  them,  followed  by  every-  est technical achievements.
            Secretary Matt Hancock said.        Other  countries  aren’t  far  behind:  one over 80 and health care workers.
                                                Regulators not only in the U.S. but in  From there, the program will be ex-  The  Russian  vaccine  won  regulato-
            The announcement sets the stage for  the European Union and Canada also  panded as the supply increases, with  ry approval in August but has yet to
            the  biggest  vaccination  campaign  in  are  vetting  the  Pfizer  vaccine  along  the  vaccine  offered  roughly  on  the  complete advanced studies of its ef-
            British  history  and  came  just  ahead  with  a  shot  made  by  Moderna  Inc.  basis of age groups, starting with the  fectiveness and safety. Health Minis-
            of what experts are warning will be a  British  and  Canadian  regulators  are  oldest people.              ter Mikhail Murashko said more than
            long, dark winter, with the coronavi-  also  considering  a  vaccine  made  by                              100,000  people  in  Russia  have  been
            rus surging to epic levels in the U.S.  AstraZeneca and Oxford University.  Despite  the  speed  with  which  they  given the shots.
            and Europe and putting pressure on                                      approved  the  vaccine,  and  the  in-
            hospitals and businesses.           Amid  growing  concern  in  the  U.S.  tense  political  pressure  surrounding  The vaccine made by Pfizer and Bi-
                                                that  Americans  will  greet  vaccines  the worldwide race to solve the crisis,  oNTech was tested in tens of thou-
            Officials cautioned that several tough  with  skepticism,  U.S.  Health  and  British  regulators  insisted  “no  cor-  sands of people, and the makers re-
            months still lie ahead even in Britain,  Human Services Secretary Alex Azar  ners have been cut” during the review  ported no serious side effects. Still to
            given  the  monumental  scale  of  the  said  Britain’s  decision  “should  give  process.                  be  determined  is  whether  the  shots
            operation  needed  to  vaccinate  large  Americans  additional  confidence  in                              protect  against  people  spreading  the
            swaths  of  the  population.  Because  the quality of such a vaccine.”  The MHRA made its recommenda-       virus without having symptoms. An-
            of the limited initial supply, the first                                tion following a so-called rolling re-  other question is how long protection
            shots will be reserved for those most  Hancock  said  Britain  will  begin  re-  view  that  allowed  it  to  assess  infor-  lasts.
            in danger, namely nursing home pa-  ceiving the first shipment of 800,000  mation about the vaccine as it became
            tients,  the  elderly  and  health  care  doses from Belgium within days, and  available, starting back in October.  The  vaccine  also  has  been  tested  in
            workers.                            people will start getting the shots as                                  only  a  small  number  of  children,
                                                soon  as  it  arrives.  Two  doses  three  “The safety of the public will always  none younger than 12, and there’s no
            Britain's  Medicines  and  Healthcare  weeks apart are required. The coun-  come first,” said Dr. June Raine, chief  information on its effects in pregnant
            Products Regulatory Agency recom-   try expects to receive millions of dos-  executive of the agency. “And I em-  women.
            mended the vaccine after clinical tri-  es by the end of this year, Hancock  phasize  again  that  this  recommen-
   25   26   27   28   29   30   31   32